Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
P 1 (2)

Trial Status

Unknown3
Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT06033976RecruitingPrimary

Endoscopic Submucosal Dissection Registry

NCT05587088Phase 1UnknownPrimary

Evaluation of the Safety and Efficacy of Esperanza Extract (PA001)

NCT03563326Phase 1UnknownPrimary

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

NCT03597672UnknownPrimary

Early Detection and Screening Strategy of Gatric Cancer in Sichuan Province-A Prospective Cohort Study (WCH-GC-SIGES-01)

Showing all 4 trials

Research Network

Activity Timeline